|
|
Application value of digital oil drop PCR method and ARMS method in detecting BRAF gene mutation in colorectal cancer |
JIANG Yanping1 XUN Yanping1 FU Jiayi1 ZHANG Shirong1 ZHAO Yanyan1 MA Shenglin2 |
1.Translational Medicine Research Center, Affiliated Hangzhou First People′s Hospital, Zhejiang University School of Medicine, Zhejiang Province, Hangzhou 310006, China;
2.Department of Oncology, Affiliated Hangzhou First People′s Hospital, Zhejiang University School of Medicine, Zhejiang Province, Hangzhou 310006, China |
|
|
Abstract Objective To explore the application value of digital oil drop polymerase chain reaction (ddPCR) and amplification hindered mutation system (ARMS) in the detection of serine/threonine protein kinase (BRAF) V600E mutation in colorectal cancer patients. Methods Surgical specimens of 162 patients with colorectal cancer treated in Affiliated Hangzhou First People′s Hospital, Zhejiang University School of Medicine from April 2018 to July 2019 were collected. ARMS method and ddPCR method were used to detect BRAF V600E mutation in colorectal cancer patients, and the positive rate and consistency of ARMS and ddPCR were compared. The relationship between BRAF V600E mutation and clinicopathological characteristics of patients with colorectal cancer were analyzed. Results The positive rates of BRAF V600E mutation detected by ARMS and ddPCR were 8.64% (14/162) and 9.26% (15/162). High-throughput sequencing was performed on one case of the ambiguity of the BRAF V600E mutation detected by the ARMS method, and the result of the ddPCR method was consistent with the high-throughput sequencing result. Corresponding to the ddPCR, the positive coincidence rate, negative coincidence rate and consistency of the ARMS method were 93.33%, 99.32% and 99.38%, respectively. The patients who were higher the age, the poorly differentiated histological type, in clinical stages Ⅲ-Ⅳ, the higher the distribution of BRAF V600E mutations, and the differences were statistically significant (P < 0.05). Conclusion Both ddPCR and ARMS can be used to detect BRAF V600E mutations in colorectal cancer, and ddPCR has higher detection efficiency.
|
|
|
|
|
[1] Brody H. Colorectal cancer [J]. Nature,2015,521(7551):S1.
[2] 王磊,宋顺心,汪建平.结直肠癌实验研究现状及展望[J].中华实验外科杂志,2013,30(3):429-430.
[3] 王宁,刘硕,杨雷,等.2018全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2019,5(1):87-97.
[4] 徐倩,王颖.结直肠癌相关肿瘤标志物与疗效、预后解读的研究进展[J].医学综述,2018,24(17):3377-3381, 3387.
[5] 李艳艳,高静,吉聪聪,等.结直肠癌KRAS、NRAS和BRAF基因罕见突变类型及其临床意义(附1513例)[J].中华消化外科杂志,2020,19(3):315-323.
[6] 张祥涛,刘睿清,张宪祥,等.BRAF V600E基因突变在结直肠癌治疗中的研究进展[J].中华结直肠疾病电子杂志,2020,9(3):292-295.
[7] 金柯,谢绚,潘越江,等.AMSS-PCR在肺癌突变基因检测中的价值研究[J].中国肺癌杂志,2018,21(11):815-820.
[8] 季盼,蒋露,丁颖,等.AMRS检测晚期非小细胞肺癌患者血液EGFR基因突变的价值[J].江苏医药,2020,46(4):404-406,416.
[9] 曹喆,王静,秦娜,等.微滴数字PCR和Super-ARMS检测晚期肺腺癌患者血浆循环肿瘤DNA表皮生长因子受体基因突变的临床价值研究[J].中国肺癌杂志,2020, 23(2):84-90.
[10] 张莹,王哲,杨向红.结直肠癌患者应用ARMS法检测KRAS、NRAS、PIK3CA、BRAF基因突变分析[J].诊断病理学杂志,2019,26(8):506-511.
[11] Pai-Dhungat J. Kary Mullis-inventor of PCR [J]. J Assoc Physicians India,2019,67(9):96.
[12] 李金明.定量聚合酶链反应测定技术[J].中华检验医学杂志,2002,25(2):123-124.
[13] 王玉倩,薛秀花.实时荧光定量PCR技术研究进展及其应用[J].生物学通报,2016,51(2):1-6.
[14] 郑志芬,戴荣继.实时荧光定量PCR技术在临床肿瘤检测中的应用[J].生命科学仪器,2014,12(3):20-23.
[15] Vogelstein B,Kinzler KW. Digital PCR [J]. Proc Natl Acad Sci USA,1999,96(16):9236-9241.
[16] 王青,刘宝瑞.液滴数字PCR在肿瘤个体化治疗方面的应用[J].现代肿瘤医学,2015,23(12):1771-1774.
[17] Quan PL,Sauzade M,Brouzes E. dPCR:A Technology Review [J]. Sensors (Basel),2018,18(4):1271.
[18] 刘聪,蒋克明,刘聪,等.微滴技术的数字PCR研究现状及发展趋势[J].化学研究与应用,2018,30(7):1041-1047.
[19] 王琦,范颖.微滴式数字PCR技术进展[J].中国医学前沿杂志:电子版,2016,8(11):15-19.
[20] 冯秀晶,易红梅,任星旭,等.数字PCR技术及其在检测领域的应用[J].遗传,2020,42(4):363-373.
[21] Xu X,Ma X,Zhang X,et al. Detection of BRAF V600E Mutation in Fine-Needle Aspiration Fluid of Papillary Thyroid Carcinoma by Droplet Digital PCR [J]. Clin Chim Acta,2019,491(4):91-96.
[22] 毛旭华,汤俊明,马芬芬,等.微滴式数字PCR技术检测非小细胞肺癌患者外周血EGFR基因突变[J].临床检验杂志,2018,36(8):589-592.
[23] 曹紫阳,吴伟,侯立坤,等.微滴数字PCR与Super-ARMS PCR检测非小细胞肺癌患者表皮生长因子受体(EGFR)酪氨酸激酶抑制剂治疗耐药后血浆游离DNA EGFR基因T790M突变的对比分析[J].中华病理学杂志,2018,47(12):910-914.
[24] 江培学,毛日成,张继明.HBV cccDNA定量检测方法的研究进展[J].临床肝胆病杂志,2019,35(6):1201-1204.
[25] 农雪萍,黄建华,冯雅莉,等.外泌体β-actin mRNA在恶性胸腔积液、结核性胸腔积液鉴别诊断中的应用价值[J].中国医学创新,2019,16(29):168-172.
[26] 杨梦园,胡涵光,陈佳琦,等.BRAF突变晚期结直肠癌的治疗进展[J].实用肿瘤杂志,2019,34(4):374-379. |
|
|
|